Dronabinol
Product Images NDC 54868-5929

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Dronabinol (NDC 54868-5929). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 5 mg Package Label (5929)

FDA Label Image

F94ee242-figure-01 (F94ee242 Figure 01)

FDA Label Image

F94ee242-figure-02 (F94ee242 Figure 02)

F94ee242-figure-02 (F94ee242 Figure 02)
The text describes a chart or a graph that shows the mean appetite change from baseline in weeks. The chart compares the effects of Dronabinol (2.5 mg BID) and a placebo. The p-value is less than 0.05, indicating that there is a statistically significant difference between the appetite changes observed in the two groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.